touchSATELLITE SYMPOSIUM for touchNEUROLOGY
Listen to this touchSATELLITE SYMPOSIUM on how to optimize diagnosis and care of patients with Alzheimer’s disease (AD), recorded live in October 2023 at the World Neurology Congress 2023 in Montreal, Canada.
Dr Sharon Cohen (behavioural neurologist from Canada), the chair for the symposium, is joined by Prof. Sven Haller (neuroradiologist from Switzerland) and Dr Ronan Factora (geriatrician from the USA).
The first session (03:40), led by Dr Sharon Cohen, focuses on the importance of an early and accurate diagnosis of AD in the DMT era. This is followed by the discussion of a patient case and audience Q&A (24:23).
In the second session (31:27), Prof. Sven Haller discusses the use of imaging and fluid biomarkers in the diagnostic process for. This is followed by the discussion of a patient case and audience Q&A (42:17).
In the third session (54:10), Dr Ronan Factora offers practical insights on how to achieve collaborative patient-centred care across the AD continuum. This is followed by the discussion of a patient case and audience Q&A (01:08:04).
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Eli Lilly and Company and is jointly provided by USF Health and touchIME.
For further information visit our website
MDT and patient advocate perspectives on what can be learned from patients with CML
MDT perspectives on maximizing quality of life for patients with CML
MDT perspectives on minimizing TKI-associated toxicities in patients with CML
MDT perspectives on later-line treatment options for CML
Extending the benefit of PARP inhibitors through combinations for advanced prostate cancer - Conversation 3
PARP inhibitor combination clinical trials for advanced prostate cancer - Conversation 2
Rationale for PARP inhibitor combinations for advanced prostate cancer - Conversation 1
ENT experts discuss minimizing the clinical burden of chronic rhinosinusitis with nasal polyposis
ENT experts discuss minimizing the clinical burden of chronic rhinosinusitis with nasal polyposis
Considerations for the selection of disease-modifying treatments in SMA: A case-based discussion
Improving patient outcomes in relapsing MS: Current oral DMTs and emerging therapies
PARP inhibitors as first-line maintenance therapy in ovarian cancer: Update from SGO 2022
MDT and patient perspectives on the role of GLP-1 RAs in the T2D management pathway
MDT and patient perspectives on the safety of GLP-1 RAs and managing their side effects
MDT discussions on the rationale for using GLP-1 as a therapeutic target in T2D
Improving patient outcomes in moderate-to-severe ulcerative colitis
AAAAI 2022: Improving outcomes for patients with eosinophilic esophagitis
AAAAI 2022: Improving outcomes for patients with eosinophilic esophagitis
Unlocking CSU pathogenesis to shape the future treatment landscape
Identifying, diagnosing and treating patients with later-onset SMA
Create your
podcast in
minutes
It is Free
DNA Today: A Genetics Podcast
The Psychic Elephant Radio Podcast
Museum of the Missing
Sasquatch Chronicles
Hidden Brain